Shubham Tyagi, Nvs Madhav, Abhijeet Ojha, Vedprakash Goswami, Upendra Rawat


In the designing and development of drug products from active drug(s), some of the important non-therapeutic substances are essentially included. These non-therapeutic substances are broadly termed as excipients. The pharmaceutical excipients and their significance have been reviewed in detail in this article. Excipients are parts of a completed medication item other than the dynamic pharmaceutical fixing (API) and are included amid detailing for a particular reason Excipients as like other dynamic pharmaceutical fixings should be settled and institutionalized. They go about as defensive operators, building specialists and can likewise be utilized to enhance bioavailability of medications in a few occurrences. Particular excipients are most appropriate for a specific dose frame.




Pharmaceutical excipients, Therapeutic substances,Co processing excipients, Excipient Interaction, Guar Gum.

Full Text:



Ansel H.C., Allen L.V., and Jr., Popovich N.G. (2005). Pharmaceutical Dosage Forms &Drug Delivery Systems, 8th ed; Lippincott Williams & Wilkins, 121-145.

Aulton M.E. (2005). Pharmaceutics – The Science of Dosage Form Design, 113-138.

Gaud R. S., Yadav A. V. and Gokhale S.B. (2004). Textbook of Pharmaceutics, 10th Ed; NiraliPrakashan, New Delhi, 102-135.

Sumie Y., Stella and Valentino J. (2006). Stability of Drugs and Dosage forms, New Delhi, Springer.

Giorgio Pifferi, PatriziaRestani†the safety of pharmaceutical excipients†farmaco 58 (8) 541- 550 (2003). 1.htm (chloroform)7. agar chips

Sari Airaksinen†excipient selection can significantly affect solid state phase transformation in formulation during wet granulation†apps pharmscitech, 2005, 6(2), E 311-E 322, DOI10.12081 pt 060241.

MdZaki Ahmad, et. al†drug excipient interactions and compatibility study; a review†J Pharm Res 2010, 3 (9), 2092-2095.

Patrik Crowley, Dr Luigi G Martini “drug excipient interactions† excipient interaction.pdf 17.D.D Wireth†maillard reaction of lactose and fluoxetime hydrochloride, a secondary amine†J Pharm Sci, 87, 31-39 (1998).

www.informahealthcare .com “excipient development for pharmaceutical biotechnology and drug delivery systems†page 93-124

FengheQiu†identification of drug excipient interaction products using stress testing assisted approach†boehringerIngelhein pharmaceuticals INC. available on www.americanpharmaceutical

Raymond C Rowe, Paul J Sheskey and Paul J Weller; Handbook of Pharmaceutical Excipients, Pharmaceutical press, American Pharmaceutical Association, 4th ed, 2003

M.C Gohel “a review of coprocessed directly compressible excipientsâ€, j.pharmpharmaceutsci ( 8(1) 26-93, 2005

Ashish A Joshi and Sergio Neves†from commodities to specialized excipients†available on

MinakshiMarwaha†co processing of excipients; a review on excipient development for tableting performance†Int j app pharmceut, 2010;2 (3), 41-47.

Mahesh Kreer†application of novel excipients in the allopathic and herbal formulations†j.chem.pharm.res, 2010, 2(4), 851- 860.

Hans Leuenberger“ from functionality excipients towards drug carrier systemâ€ChimiCaoggi. Chemistry today. Vol 24 nr5, sept/Oct 2006, page 64-66.

Ashish A Joshi and Xavier Duriez “added functionality excipients; an answer to challenging formulations†pharmaceutical technology excipients, solid dosage forms 2004,

MdZaki Ahmad, et. al†drug excipient interactions and compatibility study; a review†j pharm res; 2010, 3 (9), 2092-2095.

Kenneth C Waterman, Bruce C Macdonald “package selection for moisture protection for solid oral drug product†J Pharm Sci, 2010;99(11):4437-4452.

Dennis Jenke†evaluation of chemical compatibility of plastic contact material and pharmaceutical products; safety and considerations related to extractable and leachable†J Pharm Sci, 2007;96(10): 2566-2581.

B Marcato, S Guerra,†migration of antioxidant additives from various polyolefinic plastics into oleaginous vehicles†Int j Pharmceut, 2003;257(1-2):217-225.

Thomas Gonyon “container effects on the physicochemical properties of parentral lipid emulsions†Int j app basic nutrisci, 2008;24, (11) :1182-1188.

The IPEC excipient information package (EIP) template and user guide 2009. _final(1).pdf 33.EMEA, ICH Topic Q1 A (R2) , stability testing of new drug substance and products. Aug 2003, CPMP/ICH/2736/99. Available at ry/Scientific_guideline/2009/09/WC500002651.p df

Christopher DeMerlis, Jay Goldring, RangaVelagaleti, William Brock, and Robert Osterberg, regulatory update; the IPEC novel excipient safety evaluation procedure, Nov 2009, Volume Number 11.

Christopher DeMerlis ;Elaine V. Knight ;R. Christian Moreton ;Robert E. Osterberg, "Eye on Excipients," Tablets and capsules -formulation production and packaging vol 9, number 3, April 2011, 33-41.

PrashantSrivastava “Excipients for Semisolid Formulationsâ€excipient development for pharmaceutical biotechnology and drug delivery systems; Ashok Katdare, Mahesh V. Chaubal (ed) ©by Informa Healthcare USA, Inc, 2006;197-207. 8

Leon Lachman, Herbert A Lieberman, Joseph .L.Kanig, "the theory and practice of industrial pharmacy," , Varghese publishing house, third edition 1990; 457-471


DOI (1-12):


  • There are currently no refbacks.

© Copyright 2016. All Rights Reserved - Innovatpublisher CC BY Creative commons